Chemical Name: | 1-Butanol,2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-,(2R)- |
CAS Number: | 186692-46-6 |
Product Number: | AG003U50(AGN-PC-0QFT35) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C19H26N6O |
Molecular Weight: | 354.4493 |
Roscovitine, a potent inhibitor of cyclin-dependent kinases (CDKs), has found versatile applications in chemical synthesis due to its ability to modulate cell cycle progression. In chemical synthesis, Roscovitine serves as a valuable tool for controlling the activation of CDKs, which play a crucial role in regulating the cell cycle. By selectively inhibiting CDKs, Roscovitine can influence cell proliferation and differentiation, making it a promising candidate for manipulating cellular processes in various synthetic pathways. Researchers have leveraged the unique properties of Roscovitine to explore its potential in drug discovery, cancer therapy, and other areas where precise control over cell cycle regulation is essential. Additionally, Roscovitine has been utilized in the synthesis of novel compounds and materials, showcasing its versatility as a chemical tool in the realm of synthetic chemistry.